We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Investors Should Hold on to Verisk (VRSK) Stock
Read MoreHide Full Article
Verisk Analytics, Inc.’s (VRSK - Free Report) shares have had a decent run on the bourses over the past year, gaining 10.1% against 8.9% growth of the industryit belongs to.
The company has an expected long-term earnings per share (three to five years) growth rate of 10.2%. Its earnings are expected to increase 2.4% in 2021 and 15.3% in 2022, year over year.
Verisk has a robust growth strategy that focuses on organic growth, product development and acquisitions.
Using advanced technologies to collect and analyze data, Verisk draws on unique data assets and deep-domain expertise to provide predictive analytics and decision support solutions that are integrated into customer workflows. The company’s specialized and in-depth knowledge in markets such as energy, insurance, financial services and risk management adds value to its analytics. A steady stream of first-to-market innovations and the ability to deeply integrate into customer workflows allows the company to strengthen its client base over time.
Verisk has been consistently acquiring and investing in companies globally to expand data and analytics capabilities across industries. The recently announced acquisition of assets and capabilities of 4C Solutions will help the company expand into the group life insurance market. The 2020 acquisition of Franco Signor should help Verisk strengthen its foothold in the Medicare space.
Some Risks
Verisk’s cash and cash equivalent balance of $276 million at the end of second-quarter 2021 was well below the long-term debt level of $2.7 billion, underscoring that the company does not have enough cash to meet this debt burden. The cash level cannot even meet the short-term debt of $403 million.
The long-term expected earnings per share (three to five years) growth rate for ManpowerGroup, Cross Country Healthcare and Genpact is pegged at 24.2%, 9.9% and 14.7%, respectively.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why Investors Should Hold on to Verisk (VRSK) Stock
Verisk Analytics, Inc.’s (VRSK - Free Report) shares have had a decent run on the bourses over the past year, gaining 10.1% against 8.9% growth of the industry it belongs to.
The company has an expected long-term earnings per share (three to five years) growth rate of 10.2%. Its earnings are expected to increase 2.4% in 2021 and 15.3% in 2022, year over year.
Verisk Analytics, Inc. Price and Consensus
Verisk Analytics, Inc. price-consensus-chart | Verisk Analytics, Inc. Quote
Factors That Auger Well
Verisk has a robust growth strategy that focuses on organic growth, product development and acquisitions.
Using advanced technologies to collect and analyze data, Verisk draws on unique data assets and deep-domain expertise to provide predictive analytics and decision support solutions that are integrated into customer workflows. The company’s specialized and in-depth knowledge in markets such as energy, insurance, financial services and risk management adds value to its analytics. A steady stream of first-to-market innovations and the ability to deeply integrate into customer workflows allows the company to strengthen its client base over time.
Verisk has been consistently acquiring and investing in companies globally to expand data and analytics capabilities across industries. The recently announced acquisition of assets and capabilities of 4C Solutions will help the company expand into the group life insurance market. The 2020 acquisition of Franco Signor should help Verisk strengthen its foothold in the Medicare space.
Some Risks
Verisk’s cash and cash equivalent balance of $276 million at the end of second-quarter 2021 was well below the long-term debt level of $2.7 billion, underscoring that the company does not have enough cash to meet this debt burden. The cash level cannot even meet the short-term debt of $403 million.
Zacks Rank and Stocks to Consider
Verisk currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are ManpowerGroup (MAN - Free Report) , Cross Country Healthcare (CCRN - Free Report) and Genpact Limited (G - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The long-term expected earnings per share (three to five years) growth rate for ManpowerGroup, Cross Country Healthcare and Genpact is pegged at 24.2%, 9.9% and 14.7%, respectively.